CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

lnk01002

Small moleculeexperimental

Clinical trial activity

7 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
6
Phase 3
3
Phase 4
0

Earliest trial started Apr 8, 2021 (NCT04896112)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07237568Phase 3Aug 29, 2025Lynk Pharmaceuticals Co., Ltd
NCT06277245Phase 3Feb 6, 2024Lynk Pharmaceuticals Co., Ltd, Peking University
NCT06276998Phase 3Dec 12, 2023Lynk Pharmaceuticals Co., Ltd
NCT06085521Phase 2Jan 26, 2022Lynk Pharmaceuticals Co., Ltd, Peking University
NCT06085534Phase 2Jan 6, 2022Chinese Academy of Medical Sciences, Lynk Pharmaceuticals Co., Ltd
NCT06099535Phase 2Nov 18, 2021Chinese Academy of Medical Sciences, Lynk Pharmaceuticals Co., Ltd
NCT04896112Phase 1Apr 8, 2021Lynk Pharmaceuticals Co., Ltd
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Lynk Pharmaceuticals Co., LtdFor profit7732021
Chinese Academy of Medical SciencesAcademic/Hospital2012021
Peking UniversityAcademic/Hospital2022022
3 organizations
Page 1 / 1